Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

Kaufman Peter A.; Awada Ahmad; Twelves Chris; Yelle Louise; Perez Edith A.; Velikova Galina; Olivo Martin S.; He Yi; Dutcus Corina E.; Cortes Javier

首页> 外文期刊>Journal of Clinical Oncology >Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

【24h】

Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

机译：甲磺酸依瑞布林和卡培他滨对先前用蒽环类和紫杉烷类药物治疗的局部晚期或转移性乳腺癌患者的III期开放标签随机研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose

机译：目的

著录项

来源
《Journal of Clinical Oncology》 |2015年第6期|共8页
作者
Kaufman Peter A.; Awada Ahmad; Twelves Chris; Yelle Louise; Perez Edith A.; Velikova Galina; Olivo Martin S.; He Yi; Dutcus Corina E.; Cortes Javier;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane [J] . Kaufman Peter A., Awada Ahmad, Twelves Chris, Journal of Clinical Oncology . 2015,第6期

机译：甲磺酸依瑞布林和卡培他滨对先前用蒽环类和紫杉烷类药物治疗的局部晚期或转移性乳腺癌患者的III期开放标签随机研究
2. Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial [J] . Cortes Javier, Hudgens Stacie, Twelves Chris, Breast cancer research and treatment. . 2015,第3期

机译：在开放标签的随机3期临床试验中，接受甲磺酸艾瑞布林或卡培他滨治疗的局部晚期或转移性乳腺癌患者的健康相关生活质量
3. Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD) [J] . Toshinari Yamashita, Norikazu Masuda, Shigehira Saji, Trials . 2020,第1期

机译：Trastuzumab，Pertuzumab和Eribulin甲磺酸丁酯与曲妥珠单抗，Pertuzumab和紫罗兰作为Her2阳性，局部晚期或转移性乳腺癌的一线或二线治疗：用于随机控制，非劣势，III期的研究方案日本试验（JBCRG-M06 / Emerald）
4. HIFU for Treating Patients with Advanced Recurrent / Metastatic Cancerin Pelvis: A Preliminary Clinical Study [C] . The 3rd Asian congress on hyperthermic oncology and the 9th Chineses symposium on hyperthermic oncology . 2002

机译：HIFU治疗晚期骨盆癌复发/转移性癌症的初步临床研究
5. Utilities of metastatic breast cancer patients treated with taxanes compared to utilities of oncology nurses. [D] . Hauser, Robert Sean. 2001

机译：与肿瘤科护士相比，使用紫杉烷类治疗的转移性乳腺癌患者的效用。
6. Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane [O] . Peter A. Kaufman, Ahmad Awada, Chris Twelves, -1

机译：甲磺酸依瑞布林与卡培他滨对先前用蒽环类和紫杉烷类药物治疗的局部晚期或转移性乳腺癌患者的III期开放标签随机研究
7. Phase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane [O] . Kaufman, Peter P.A., Perez, Edith A, Olivo, Martin M., 2015

机译：甲磺酸艾瑞布林联合卡培他滨治疗局部局部晚期或转移性乳腺癌的先前接受蒽环类和紫杉烷类药物治疗的III期开放标签随机研究

Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

摘要

著录项

相似文献

相关主题

期刊订阅